| INTRODUCTION
Ehrlichia ewingii is an obligate intracellular bacterium that predominantly infects granulocytes, causing granulocytic ehrlichiosis in dogs and humans. 1, 2 Acute granulocytic ehrlichiosis in dogs is characterized most often by fever, thrombocytopenia, and joint pain. Of comparative medicine and zoonotic disease importance, granulocytic ehrlichiosis in humans previously has been reported in immunosuppressed patients, but more recent reports document most cases occurring in immunocompetent patients. [3] [4] [5] [6] [7] [8] Clinical abnormalities in human patients often consist of fever, myalgia, headache, nausea, vomiting, acute renal failure, leukopenia, thrombocytopenia, and increased liver enzyme activities.
Using Ehrlichia species-specific peptides, recent studies indicate that E. ewingii is the most seroprevalent tick-transmitted Ehrlichia spp.
affecting dogs in the United States. [9] [10] [11] The primary vector for E. ewingii is Amblyomma americanum, an aggressive tick that feeds on multiple reservoir hosts, including white-tailed deer, reptiles, birds, and dogs. 12 In contrast, Ehrlichia canis is vectored by Rhipicephalus sanguineus (sensu lato), a tick most often associated with dog kennels and that primarily feeds on canids as reservoir hosts. 13 Tick ecology and behavior partially may explain differences in E. canis (0.8%) and
E. ewingii (5.1%) seroprevalence rates among dogs in the South and
Central regions of the United States. 9 Based on several studies involving naturally and experimentally infected dogs, canine granulocytic ehrlichiosis (CGE), caused by E. ewingii, has been associated with less severe clinical signs relative to canine monocytic ehrlichiosis (CME), caused by E. canis.
11, [14] [15] [16] [17] [18] [19] [20] Dr. Sidney Ewing initially observed E. ewingii as morulae in the neutrophils of dogs with thrombocytopenia and polyarthritis. 1 With the advent of molecular phylogenetics, E. ewingii was later identified as a species distinct from E. canis based on 16S rRNA gene sequence analyses. 2 Clinicopathologic abnormalities reported in dogs with CGE include fever, lameness, neurological abnormalities, lymphadenomegaly, peripheral edema, neutrophilic polyarthritis, thrombocytopenia, and leukopenia. [14] [15] [16] [17] 19, 20 Several of these studies also reported E. ewingii-infected dogs with no clinical abnormalities.
Dogs experimentally infected with E. ewingii after exposure to
A. americanum continued to harbor E. ewingii DNA, indicated by continuous PCR-positive results, for up to 2 years without developing overt clinical disease. 18 It is not clear why a subset of E. ewingiiinfected dogs develop clinical disease, whereas others immunologically eliminate the infection or remain subclinical and persistently infected. Possible reasons include differences in the overall health status of individual dogs, E. ewingii strain variance, the presence of coinfections, or some combination of these factors. Coinfections caused by vector-borne pathogen can produce atypical clinical presentations and increase illness severity. Previous studies of dogs naturally infected with E. ewingii did not test for concurrent infections with other vectorborne pathogens, except Ehrlichia chaffeensis or Anaplasma spp. in some reports. 11, [14] [15] [16] 18, 19 The purpose of our study was to characterize disease manifestations in a large number of naturally infected, E. ewingii PCRpositive dogs that were concurrently PCR negative using a panel of other common canine vector-borne pathogens (CVBP). 
| Clinical diagnoses
Medical record data were extracted and reviewed for primary com- 
| Physical examination findings
Physical examination findings varied and were nonspecific (Figure 2 ).
The most frequently recorded physical examination findings were limb 
| Laboratory abnormalities
Complete blood counts were available for 37 of 41 (90.2%) dogs ( 
| DISCUSSION
Including dogs with renal disease, proteinuria was detected in a high number of E. ewingii PCR-positive dogs (20/27; 74%) in our study, most of which had inactive urine sediments. When compared to previous studies, the high proportion of E. ewingii-infected dogs with proteinuria (74%) or kidney disease (17.1%) represented the most notable clinicopathological finding in our retrospective descriptive study. To our knowledge, only 1 natural infection CGE study reported proteinuria in dogs with active sediments (2/5; 40%). 16 One study showed that 79% of dogs with CME were proteinuric. 23 In our study, PLN and CKD were diagnosed in 1 and 6 dogs, respectively, with disease onset ranging from 1 month to 2 years before documentation of an E. ewingii PCR-positive result; 4 of those dogs presented with A-CKD.
The chronic kidney disease in these dogs is likely multifactorial. As often occurs, the etiology of kidney disease was not definitively determined for the dogs in our study. The UP/C ratios, available for 6 of 7 dogs with renal disease, indicated glomerular pathology such as glomerulonephritis. Leptospirosis results were negative for the 4 dogs tested. In addition to renal causes of proteinuria, prerenal conditions may contribute to proteinuria. Most of the proteinuric dogs in our study with an inactive sediment and a blood pressure measurement were normotensive (70%). Three other proteinuric A-CKD or CKD dogs were diagnosed with concurrent pancreatitis, which could have contributed, in part, to the proteinuria. Ehrlichia is considered a potential etiological agent for glomerular disease that may induce glomerular injury secondary to immune complex deposition. [24] [25] [26] Membranoproliferative glomerulonephritis was reported in a human infected with E. chaffeensis. glomerulopathy. 28 Seven hypoalbuminemic dogs in our study had concurrent proteinuria. Necropsy of 1 proteinuric, non-azotemic dog in our study identified lymphoplasmacytic interstitial nephritis and glomerular amyloidosis. United States diagnosed with IMHA, ITP, or both, 30% were exposed to or infected with a CVBP, and the most prevalent pathogen detected by PCR was E. ewingii (7%). 29 E. ewingii was reported in 3 IMHA dogs in southern California. 31 Historically, a comprehensive diagnostic approach to rule in or rule out infection with CVBP in dogs with IMHA or ITP has not been consistently pursued. 30, 31 Clinicians are more likely to test for Babesia infections, because hemolytic anemia often is linked with this particular CVBP. 32, 33 Based on previous reports and our study, E. ewingii may play a more important role in the pathogenesis of IMHA and ITP than previously suspected. Also, recent evidence supports CVBP misdiagnosis in dogs that were subsequently PCR positive after immunosuppressive drug treatment. 31 Immunosuppressive treatment in dogs with occult intravascular CVBP infections may in part contribute to the high mortality rate in dogs with IMHA.
Concentrations
Physical examination findings were nonspecific, involved multiple organ systems, and varied substantially among individual dogs. Consistent with previous reports of E. ewingii-infected dogs, limb or joint pain was the most common physical examination finding in our study. 14, 19, 20 Cardiac abnormalities were the 2nd most common phys- Two other studies reported reactive lymphocytes in 35%-38% of E. ewingii-infected dogs. 14, 19 Nine (24.3%) of the dogs in our study had reactive lymphocytes, but all were within the reference intervals.
Mild to moderate neutrophilia was identified in 56.8% of the dogs in our study, supporting the presence of a mild inflammatory response.
Neutrophilia has been reported in 30%-33% of dogs naturally infected with E. ewingii. 14, 16 Less than half of the E. ewingii-infected dogs (43.2%) in our study were thrombocytopenic. Thrombocytopenia was more frequent in other reports of E. ewingii-infected dogs, ranging from 83% to 100% of affected dogs, potentially because of preferential clinician selection of thrombocytopenic dogs for testing. 14, 16, 19, 20 Variation could represent selection criteria for testing, virulence differences among E. ewingii strains, pathophysiological differences in host response during various stages of infection (acute, subclinical, and chronic), or decreased clinical disease because of a previous E. ewingii infection. Two dogs experimentally infected with E. ewingii, treated with doxycycline, and then E. ewingii challenged did not develop thrombocytopenia, unlike naive dogs infected with E. ewingii. 17 Mild increases in ALT and ALP activities were the most common serum biochemical abnormalities identified in our study. Increased liver enzyme activities also have been reported for dogs infected with E. ewingii, E. canis, and Anaplasma phagocytophilum. 14,39-42 Hepatic involvement with mild increases in liver enzyme activities is a common finding in people with ehrlichiosis. 37 In addition to more historically associated hematological abnormalities such as thrombocytopenia, veterinarians should consider screening for CGE when abnormal or reactive lymphocytes, neutrophilia, and increased ALT or ALP activities are observed in their canine patients.
The NLR was increased in a large portion of dogs (73%) in our study. Increased NLR is an indicator of systemic inflammation and is associated with increased circulating cytokines. 43 Neutrophil-to-lymphocyte ratio has been used as a prognostic factor in both humans and dogs with malignancies. 44 Vector-borne coinfections are not uncommon in dogs with vector exposures. 58 Because coinfections often produce atypical clinical presentations and increase illness severity, we attempted to systematically exclude coinfections with known CVBP by PCR testing.
Diagnostically, PCR is a sensitive molecular-based assay for detecting CVBP, but a negative PCR result cannot definitively rule out an infection. The vector-borne pathogen load can vary depending on the organism and stage (acute versus chronic) of infection. In an effort to assess study results in the context of E. ewingii-PCR positivity, all the dogs in our study were blood PCR negative for other CVBP and most were concurrently seronegative. We did not eliminate dogs that were seroreactive to other CVBP that may only signify prior exposures. The larger number of dogs in our study that were R. rickettsii seroreactive likely indicates antibodies to spotted-fever group rickettsia (SFGR), which are prevalent among dogs in the southeastern United States. 59 This high seroprevalence is not reflective of a prior or current case of Rocky Mountain spotted fever, but rather exposure to less pathogenic, more prevalent SFGR. 60, 61 Our retrospective study had several limitations. The dogs evaluated in our study were selected from a population of dogs from which clinicians submitted samples for CVBP diagnostic testing. Thus, there 
